EBMT 2019 | Inhibiting the JAK pathway to prevent GvHD

Name: Inhibiting the JAK pathway to prevent GvHD
Uploaded: 2019-03-29T17:59:00.000Z
Duration: 2 min 44 s
Description: Here, John DiPersio, MD, PhD, of Washington University School of Medicine, St. Louis, MO, talks about JAK pathway inhibitors for the treatment and prevention of graft-versus-host disease. Dr DiPersio was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

John DiPersio • 29 Mar 2019

EBMT 2019

General

Here, John DiPersio, MD, PhD, of Washington University School of Medicine, St. Louis, MO, talks about JAK pathway inhibitors for the treatment and prevention of graft-versus-host disease. Dr DiPersio was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.